Wearing masks helps us keep each other safe. Masks are required in our facilities.
If you cannot wear a mask, contact your care team before you visit to discuss telehealth. Patients and visitors not wearing masks will not be permitted to enter.
Cancer Types & Treatments
NCI CANCER CENTER
Patients & Caregivers
Becoming Our Patient
Cancer Education
Tools & Resources
For Caregivers
Support Services
Survivorship & Hope
Clinical Trials
Find a Clinical Trial
Reasons to Participate
How to Join a Clinical Trial
For Professionals & Partners
Research
Areas of Research
Research Programs
Research That Transforms
Give Back to Research
Training & Education
Faculty Development
Graduate Education
Fellowship & Residency
High School & Undergraduate
Outreach & Prevention
Outreach & Community Initiatives
Prevention & Risk Reduction
Cancer Awareness
Scientists and medical professionals have long debated whether e-cigarettes are a safer alternative to traditional cigarettes. A new study provides some insight.
Grant will accelerate precision medicine for pediatric cancer care.
Recognizing cancer center members and supporters.
Patients participating in The Leukemia & Lymphoma Society’s (LLS) precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published in the prestigious Nature Medicine journal.
KANSAS CITY, KAN. – The University of Kansas Health System has launched a specialized dense breast care program coinciding with breast cancer awareness month in October. The program helps women who have dense breast tissue understand their risk for...
New grant will support efforts to create more patient-centered research.
A one-year, $500,000 grant from the National Cancer Institute (NCI) will bring more clinical trial opportunities to cancer patients living in Kansas.
Elizabeth Calhoun, PhD, MEd, has been named professor in the department of Population Health and associate dean for population health at the University of Kansas Medical Center.
The University of Kansas Cancer Center’s status as a community site of the National Cancer Institute’s Community Oncology Research Program (NCORP) has been renewed following a successful first year.
Ganguly has been named the A. Drue Jennings Professor in Medical Oncology.
A unique partnership between a researcher usually focused on cancer and a researcher usually focused on cystic fibrosis has resulted in an investigator-initiated clinical trial.
Rosemary, a fragrant herb frequently used in recipes and perfumes, may contain properties that prevent breast cancer from progressing.
Stefan Bossmann, PhD, has joined KU Cancer Center as a member of the Drug Discovery, Delivery and Experimental Therapeutics research program.
Kansas City, Kan. ― The University of Kansas Health System now offers radioembolization, also known as Y-90, as an outpatient procedure at The University of Kansas Hospital in Overland Park. Our fellowship-trained interventional radiologists speciali...
U.S. News & World Report released its 2020-21 Best Hospitals rankings on July 28. The cancer program at The University of Kansas Hospital is recognized among the top 10% of all hospitals in the nation. U.S. News evaluates hospitals on a series of a...